ArrowMark Colorado Holdings LLC Has $6.25 Million Stock Position in Transcat, Inc. $TRNS

ArrowMark Colorado Holdings LLC grew its position in Transcat, Inc. (NASDAQ:TRNS) by 45.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 85,371 shares of the scientific and technical instruments company’s stock after purchasing an additional 26,659 shares during the quarter. ArrowMark Colorado Holdings LLC owned about 0.92% of Transcat worth $6,249,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. State of Alaska Department of Revenue acquired a new position in shares of Transcat during the 3rd quarter worth approximately $40,000. Lazard Asset Management LLC bought a new position in Transcat in the second quarter valued at approximately $54,000. PNC Financial Services Group Inc. raised its holdings in shares of Transcat by 1,118.2% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock worth $92,000 after buying an additional 984 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in Transcat by 245.5% during the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after acquiring an additional 798 shares in the last quarter. Finally, Jones Financial Companies Lllp grew its holdings in shares of Transcat by 79.2% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,634 shares of the scientific and technical instruments company’s stock valued at $120,000 after purchasing an additional 722 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Price Performance

TRNS stock opened at $73.95 on Monday. The company’s 50-day moving average is $70.12 and its 200-day moving average is $67.35. The stock has a market capitalization of $689.95 million, a PE ratio of 87.00 and a beta of 0.71. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.21 and a quick ratio of 1.85. Transcat, Inc. has a 1 year low of $50.23 and a 1 year high of $97.08.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.04). Transcat had a net margin of 2.47% and a return on equity of 6.15%. The firm had revenue of $83.86 million during the quarter, compared to analyst estimates of $80.99 million. Equities research analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on TRNS. Zacks Research upgraded Transcat from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 4th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $105.33.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.